A carregar...
Why Bigger Is Better For Controlling Oncology Spend: It offers less competition – perhaps – but can be a boon for evidence-based pathway initiatives.
Oncology practices nationwide face rising maintenance costs and lower reimbursements for biologic therapies. It’s even tougher for small community-based practices, which often lag in adopting new standards of cancer care. Group purchasing organizations claim they have the market clout that oncologis...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioCommunications LLC
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3086127/ https://ncbi.nlm.nih.gov/pubmed/22478845 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|